摘要
目的:观察痰热清与头孢哌酮舒巴坦钠联用与单用头孢哌酮舒巴坦钠治疗老年肺部感染的临床疗效。方法:选择老年肺部感染82例,随机分为治疗组42例为痰热清与头孢哌酮舒巴坦钠联用组,对照组40例为单用头孢哌酮舒巴坦钠组。结果:治疗组的临床疗效明显优于对照组,并能缩短病程,(P<0.05),具有统计学意义。结论:痰热清注射液联用头孢哌酮舒巴坦钠治疗老年肺部感染比单用头孢哌酮舒巴坦钠疗效好,大大缩短病程,且未发现明显副作用。
Objective: To evaluate the effects combined with Tanreqing and Cefoperazone and Sulbactam Sodium or Cefoperazone and Sulbactam Sodium alone in the treatment of old people,s lung infections. Methods: To choose 82 cases patients who get inflected in lung, divide them into two groups, the therapy group which has 42 patients combined with Tanreqing and Cefoperazone and Sulbactam Sodium, the other group which has 40 patients with Cefoperazone and Sulbactam Sodium alone. Results: The treatment effects of the therapy group is much better than the other group , and the therapy group can shorten the course of disease( P 〈0.05 ), this has statistics significance. Conclusion: To compare with the treatment effects of old people's lung infections with Cefoperazone and Sulbactam Sodium alone, the treatment effects of old people's lung infections combined with Tanreqing and Cefoperazone and Sulbactam Sodium is much better and can shorten the course of disease significantly, and there isn't any negative side effects.
出处
《中国医药导刊》
2008年第2期244-245,共2页
Chinese Journal of Medicinal Guide
关键词
痰热清注射液
头孢哌酮舒巴坦钠
老年肺部感染
Tanreqing injection
Cefoperzaone and Sulbactam Sodium injection i Old people's lung infection